Uterine serous carcinoma.
Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Enomoto T, Takehara K, Denys H, Nout RA, Lorusso D, Vaughan MM, Bini M, Takano M, Provencher D, Indini A, Sagae S, Wimberger P, Póka R, Segev Y, Kim SI, Candido Dos Reis FJ, Lopez S, Mariani A, Leitao MM Jr, Raspagliesi F, Panici PB, Di Donato V, Muzii L, Colombo N, Scambia G, Pignata S, Monk BJ.
Gynecol Oncol. 2021 Jul;162(1):226-234. doi: 10.1016/j.ygyno.2021.04.029. Epub 2021 Apr 30.
Ovarian cancer metastasis: Looking beyond the surface.
Bayraktar E, Chen S, Corvigno S, Liu J, Sood AK.
Cancer Cell. 2024 Oct 14;42(10):1631-1636. doi: 10.1016/j.ccell.2024.08.016. Epub 2024 Sep 12.
HER2 Testing and Reporting in Endometrial Serous Carcinoma: Practical Recommendations for HER2 Immunohistochemistry and Fluorescent In Situ Hybridization: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
Buza N.
Int J Gynecol Pathol. 2021 Jan;40(1):17-23. doi: 10.1097/PGP.0000000000000711.
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.
Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C.
Int J Mol Sci. 2019 Feb 22;20(4):952. doi: 10.3390/ijms20040952.
Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma.
Deng Y, Tan Y, Zhou D, Bai Y, Cao T, Zhong C, Huang W, Ou Y, Guo L, Liu Q, Yin D, Chen L, Luo X, Sun D, Sheng X.
Front Immunol. 2022 Jul 22;13:923194. doi: 10.3389/fimmu.2022.923194. eCollection 2022.
Low-grade serous ovarian carcinoma: an evolution toward targeted therapy.
Voutsadakis IA.
Int J Gynecol Cancer. 2020 Oct;30(10):1619-1626. doi: 10.1136/ijgc-2019-000832. Epub 2019 Nov 27.
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study.
Negri S, Fisch C, de Hullu JA, van Bommel M, Simons M, Bogaerts J; Consortium STIC focusgroup; Hermens RPMG, Steenbeek MP.
BJOG. 2024 Dec;131(13):1851-1861. doi: 10.1111/1471-0528.17919. Epub 2024 Jul 25.
Endometrial serous carcinoma with a corded and hyalinized pattern: a clinicopathological and molecular analysis.
Travaglino A, Santoro A, Arciuolo D, Scaglione G, Raffone A, Piermattei A, Onori ME, Minucci A, Pedone Anchora L, Fanfani F, Zannoni GF.
Pathologica. 2024 Jun;116(3):176-179. doi: 10.32074/1591-951X-974.
Uterine serous carcinoma and uterine carcinosarcoma: molecular features, clinical advances, and emerging therapies.
Lee EK, Liu JF.
Clin Adv Hematol Oncol. 2024 Jul-Aug;22(6):301-310.
Low-grade serous carcinoma: molecular features and contemporary treatment strategies.
Angarita AM, Cholakian D, Fader AN.
Expert Rev Anticancer Ther. 2015;15(8):893-9. doi: 10.1586/14737140.2015.1052411. Epub 2015 Jun 3.
